Paul W. Denton

University of Nebraska at Omaha — United States

Immunology and Microbiology · Life Sciences

35h-index5.1kcitations97works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(59), HIV/AIDS Research and Interventions(32), Immune Cell Function and Interaction(23), HIV/AIDS drug development and treatment(22), HIV-related health complications and treatments(10)

Publications97 total

HIV-induced sialoglycans on infected CD4+ T cells promote immune evasion from myeloid cell-mediated killing
Nature Communications·2025Open Access
Inhibiting Glycan Degradation Prevents HIV-Induced Inflammaging and Cognitive Impairment
2025Open Access
Stabilin-1 in Tumor-Associated Macrophages: A Potential Therapeutic Target in Cancer Immunotherapy
Biology·2025· 1 citedOpen Access
The promise and perils of humanized mice: workshop report from the 29th scientific conference of the society on NeuroImmune pharmacology (SNIP)
NeuroImmune Pharmacology and Therapeutics·2025Open Access
HIV-Induced Sialoglycans on Infected Cells Promote Immune Evasion from Myeloid Cell-Mediated Killing
2025Open Access
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Scientific Reports·2024· 4 citedOpen Access
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia
JCI Insight·2024· 9 citedOpen Access
Development and implementation of natural killer cell simultaneous ADCC and direct killing assay
Heliyon·2023· 2 citedOpen Access
Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria
Bioorganic & Medicinal Chemistry·2023· 4 cited
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
Nature Medicine·2023· 68 citedOpen Access
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Nature Communications·2022· 84 citedOpen Access
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
Nature Medicine·2022· 121 citedOpen Access
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy
Frontiers in Cellular and Infection Microbiology·2022· 5 citedOpen Access
HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
EBioMedicine·2022· 1 citedOpen Access
Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus
Lupus·2022· 1 cited
Modest de novo Reactivation of Single HIV-1 Proviruses in Peripheral CD4+ T Cells by Romidepsin
Frontiers in Virology·2021· 3 citedOpen Access
The size and culturability of patient-generated SARS-CoV-2 aerosol
Journal of Exposure Science & Environmental Epidemiology·2021· 143 citedOpen Access
Predicting Cognitive Rehabilitation Needs in Patients with Central Nervous System Infections Using Montreal Cognitive Assessment
SN Comprehensive Clinical Medicine·2021· 7 cited
Poor compliance with an antibiotic directive—A call for intensified monitoring
International Journal of Infectious Diseases·2021Open Access
Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice
UNC Libraries·2020Open Access
page 1 of 5Next →

Frequent Co-authors

Martin Tolstrup(23), Ole S. Søgaard(20), J. Víctor García(20), Rikke Olesen(19), Lars Østergaard(17), Thomas A. Rasmussen(12), Mariane Høgsbjerg Schleimann(10), Jacob D. Estes(8), Angela Wahl(8), Tomonori Nochi(7), John F. Krisko(6), Line K. Vibholm(6), Florence A. Othieno(5), Anja K. Wege(5), Steffen Leth(5), Wei Zou(5), Michael W. Melkus(4), Ashley T. Haase(4), Bangdong L. Wei(4), Michael D. Swanson(4)